Nasal Drops Hold Promise in Fighting Deadly Brain Cancer

2 days ago
Chris@BMW

The fight against glioblastoma, a deadly brain cancer, has been boosted by new research conducted at Washington University that has…

Cancer Immunotherapy Could Be Boosted by Targeting Pathways of DNA Repair

3 days ago

A newly published study shows that the fight against cancer could be boosted by considering approaches that seek to disrupt…

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

3 days ago

BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare…

Could Copying Lessons from Europe Help America Fix its Healthcare System?

5 days ago

The steep cost of healthcare in the U.S. has always been, and is becoming an even bigger political issue with…

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

5 days ago

BioMedWire Editorial Coverage: Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the…

Soligenix Inc. (NASDAQ: SNGX) Reaches Key Enrollment Milestone in Phase 3 Trial with Encouraging Blinded Response Rate

6 days ago

The enrollment milestone represents a crucial step forward for the FLASH2 study, which builds upon the previous statistically significant Phase…

Study Uncovers Surprising Connection Between Choline, Obesity and Brain Inflammation

6 days ago

For a long time, the scientific community has known that anything that causes harm to the body usually also harms…

Soligenix Inc. (NASDAQ: SNGX) Elevates Advisory Network as Rare Disease Strategy Advances

2 weeks ago

Philipson will serve as a strategic advisor to Soligenix, contributing extensive expertise in U.S. economic policy, healthcare regulation and corporate…

Common Drug for Blood Pressure Could Slow Glioblastoma

2 weeks ago

Researchers studying how a common drug, hydralazine, for blood pressure and preeclampsia works at the cellular level have identified the…

Soligenix Inc. (NASDAQ: SNGX) Strengthens CTCL Program as DMC Flags No Safety Issues

2 weeks ago

This milestone is significant because regulatory pathways for orphan diseases such as CTCL often hinge not only on efficacy, but…